Taro Recalls Children's Ibuprofen Suspension Due to Plastic Particles
Taro Pharmaceuticals is recalling 5,280 bottles of Children's Ibuprofen Oral Suspension due to the presence of small inert plastic particles.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the hazard involves inert plastic particles with no reported injuries or illnesses, fitting the criteria for a moderate risk.
Plain-English summary
Taro Pharmaceuticals U.S.A., Inc. is recalling 5,280 bottles of Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-Free, Alcohol Free, 4 fl. oz. (120 mL). The product is distributed by Winco Foods, LLC, and carries the NDC 67091-321-04. The specific lot affected is A972834374, with an expiration date of 12/20.
The recall was initiated because the medication may contain small particles of an inert plastic material that were introduced during the manufacturing process. The affected product was distributed nationwide in the United States.
Consumers should check their inventory for the specific lot number and expiration date listed above. If the product matches the recalled lot, consumers should stop using it and contact Taro Pharmaceuticals or their healthcare provider for instructions on how to dispose of the medication or obtain a replacement.
The recalled product
- Product
- Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-Free, Alcohol Free, 4 fl. oz.(120 mL), Distributed by: Winco Foods, LLC, Boise, ID 83704, NDC 67091-321-04
- Manufacturer
- Taro Pharmaceuticals U.S.A., Inc.
- Category
- Drug — Oral Suspension
- Affected units
- 5,280
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: A972834374
- Exp 12/20
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Taro Pharmaceuticals U.S.A., Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Taro Pharmaceuticals U.S.A., Inc.
See all →- ModerateHydrocortisone & Acetic Acid Otic Solution Recalled for Potency and Impurity Failures
FDA (Drugs) · 2024-08-21
- ModerateClotrimazole and Betamethasone Topical Cream Recalled for Failed Potency Specifications
FDA (Drugs) · 2022-04-06
- SevereClobetasol Propionate Ointment Recalled for Microbial Contamination
FDA (Drugs) · 2022-01-19
- HighTaro Recalls Nortriptyline Hydrochloride Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2021-02-10
- ModerateTaro Recalls Rite Aid Clotrimazole Cream Due to Impurity
FDA (Drugs) · 2020-12-23
Same hazard · foreign substance
See all →- ModerateHeritage Pharmaceuticals Recalls Clindamycin Palmitate Hydrochloride Due to Foreign Particles
FDA (Drugs) · 2026-08-19
- HighPrednisolone Acetate Ophthalmic Suspension Recalled for Foreign Substance
FDA (Drugs) · 2026-07-08
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- LowHydroxyzine Hydrochloride Oral Solution recalled for foreign substance
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01